Gocke A - Search Results

1

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.

Coyle PK, Gocke A, Vignos M, Newsome SD. Coyle PK, et al. Among authors: gocke a. Adv Ther. 2021 Jul;38(7):3550-3588. doi: 10.1007/s12325-021-01761-3. Epub 2021 Jun 1. Adv Ther. 2021. PMID: 34075554 Free PMC article. Review.

2

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.

Coyle PK, Gocke A, Vignos M, Newsome SD. Coyle PK, et al. Among authors: gocke a. Adv Ther. 2022 Jan;39(1):822-830. doi: 10.1007/s12325-021-01967-5. Adv Ther. 2022. PMID: 34792786 Free PMC article. No abstract available.

3

1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls.

Bhargava P, Gocke A, Calabresi PA. Bhargava P, et al. Among authors: gocke a. J Neuroimmunol. 2015 Feb 15;279:20-4. doi: 10.1016/j.jneuroim.2014.12.018. Epub 2015 Jan 3. J Neuroimmunol. 2015. PMID: 25669995

4

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.

Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, Gocke A, Steinman L, Mowry EM, Calabresi PA. Sotirchos ES, et al. Among authors: gocke a. Neurology. 2016 Jan 26;86(4):382-90. doi: 10.1212/WNL.0000000000002316. Epub 2015 Dec 30. Neurology. 2016. PMID: 26718578 Free PMC article. Clinical Trial.

5

1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.

Grishkan IV, Fairchild AN, Calabresi PA, Gocke AR. Grishkan IV, et al. Among authors: gocke ar. Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21101-6. doi: 10.1073/pnas.1306072110. Epub 2013 Dec 9. Proc Natl Acad Sci U S A. 2013. PMID: 24324134 Free PMC article.

6

Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.

Grishkan IV, Tosi DM, Bowman MD, Harary M, Calabresi PA, Gocke AR. Grishkan IV, et al. Among authors: gocke ar. J Immunol. 2015 Aug 15;195(4):1399-1407. doi: 10.4049/jimmunol.1403024. Epub 2015 Jul 6. J Immunol. 2015. PMID: 26150529 Free PMC article.

7

Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells.

Grishkan IV, Ntranos A, Calabresi PA, Gocke AR. Grishkan IV, et al. Among authors: gocke ar. Cell Immunol. 2013 Jul-Aug;284(1-2):68-74. doi: 10.1016/j.cellimm.2013.06.011. Epub 2013 Jul 2. Cell Immunol. 2013. PMID: 23933188 Free PMC article.

8

Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases.

Mullen KM, Gocke AR, Allie R, Ntranos A, Grishkan IV, Pardo C, Calabresi PA. Mullen KM, et al. Among authors: gocke ar. J Neuroimmunol. 2012 Aug 15;249(1-2):86-92. doi: 10.1016/j.jneuroim.2012.04.017. Epub 2012 May 24. J Neuroimmunol. 2012. PMID: 22633193 Free PMC article.

9

Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes.

Hu L, Wang T, Gocke AR, Nath A, Zhang H, Margolick JB, Whartenby KA, Calabresi PA. Hu L, et al. Among authors: gocke ar. PLoS One. 2013;8(1):e54267. doi: 10.1371/journal.pone.0054267. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23382885 Free PMC article.

10

FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.

Ntranos A, Hall O, Robinson DP, Grishkan IV, Schott JT, Tosi DM, Klein SL, Calabresi PA, Gocke AR. Ntranos A, et al. Among authors: gocke ar. J Neuroimmunol. 2014 May 15;270(1-2):13-21. doi: 10.1016/j.jneuroim.2014.03.007. Epub 2014 Mar 11. J Neuroimmunol. 2014. PMID: 24680062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters